Peer-reviewed veterinary case report
Insulin glargine safely lowers blood sugar in diabetic dogs
By Fracassi, F et al.·Published in The Veterinary record·2012·Department of Veterinary Medical Sciences, Italy·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Use of insulin glargine in dogs with diabetes mellitus.
- Species:
- dog
Plain-English summary
Twelve dogs with diabetes were treated with insulin glargine, an injectable insulin, given every 12 hours for at least six months. After just two weeks, their blood sugar levels dropped significantly and stayed lower throughout the study. By the end of the 24 weeks, most dogs showed improvement in symptoms like excessive urination and thirst, with 58% achieving good blood sugar control. The treatment was considered safe, with no signs of low blood sugar observed. Insulin glargine could be a viable option for managing diabetes in dogs.
People also search for: dog diabetes treatment · insulin glargine for dogs · symptoms of diabetes in dogs
Abstract
The objective of this study was to evaluate the safety and efficacy of insulin glargine in dogs with diabetes mellitus (DM). Twelve client-owned dogs with DM were included. All dogs received insulin glargine every 12 hours for at least six months, re-evaluations were performed after one, two, four, eight, 12 and 24 weeks and included clinical signs, blood glucose curves (BGCs) and measurement of serum fructosamine concentrations. Mean blood glucose concentrations were significantly lower after two weeks of treatment and remained significantly lower for the duration of the study. By week 24, polyuria/polydipsia had improved in 91 per cent of the dogs. No clinical signs that could have been caused by hypoglycaemia were observed. Based on BGCs and remission of the clinical signs for judging the success of the treatment, 58, 33 and 8 per cent of the dogs attained good, moderate and poor glycaemic control by week 24 of the study, respectively. Insulin glargine administered subcutaneously twice daily is a possible and safe method of treatment for dogs with naturally occurring DM. Although only a few studies are available on the use of other types of insulin in dogs, their success rate is somewhat greater than that with insulin glargine.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/22008227/